Control of cardiovascular risk factors and its determinants in the general population- findings from the STAAB cohort

Theresa Tiffe1,2, Martin Wagner1,2, Viktoria Rücker1

  • 1Institute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany.

Insights

Vascular risk factors are common and poorly controlled in the general population. Improving control is crucial for cardiovascular disease prevention, requiring further research into barriers.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Vascular risk factor control is often insufficient in primary care.
  • Limited data exists on vascular risk factor control in the general population.
  • This study investigates risk factor control in individuals without cardiovascular disease (CVD).

Purpose of the Study:

  • To assess the prevalence of adequate vascular risk factor control in the general population.
  • To identify determinants associated with the accumulation of uncontrolled vascular risk factors.
  • To inform primary prevention strategies for cardiovascular disease.

Main Methods:

  • Utilized data from the STAAB Cohort Study (Würzburg, Germany).
  • Included 1379 participants aged 30-79 without established CVD.
  • Assessed control of hypertension, dyslipidemia, diabetes, physical inactivity, overweight, and smoking against 2016 ESC guidelines.

Main Results:

  • High prevalence of physical inactivity (30.8%), overweight (55.2%), and smoking (19.3%).
  • Hypertension (31.8%), dyslipidemia (57.6%), and diabetes (3.9%) were prevalent.
  • Treatment goals were unmet in over 50% of hypertensive, 37% of hyperlipidemic, and 44% of diabetic participants.
  • Insufficient risk control linked to male sex, older age, and lower education levels.

Conclusions:

  • Vascular risk factors are highly prevalent in the general population.
  • Identification and control of these risk factors are inadequate.
  • Significant potential exists to improve adherence to cardiovascular guidelines for primary prevention.
  • Further research is needed to address patient- and physician-related barriers to effective risk factor management.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
465
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
741
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
947
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
489
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
7.4K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K